Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma

Cancer Letters

Volumn 354, Issue 1, 2014, Pages 77-86

  Li, Zhigang ^a   Li, Xinxin ^b   Li, Chunguang ^c   Su, Yinghan ^d   Fang, Wentao ^a   Zhong, Chenxi ^a   Ji, Weidan ^e   Zhang, Qian ^e   Su, Changqing ^e  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d XI AN JIAOTONG LIVERPOOL UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cyclin; Esophageal cancer; Gene expression; Transcription factor

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; CCND1 PROTEIN, HUMAN; CYCLIN D1; CYCLINE; POU5F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CCND1 GENE; CELL CYCLE PROGRESSION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; TUMOR XENOGRAFT; WILD TYPE; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA; CELL CYCLE; CELL DIVISION; ESOPHAGUS CANCER; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; TUMOR CELL LINE; TUMOR INVASION;

MUS MUSCULUS;

CELL CYCLE; CYCLIN; ESOPHAGEAL CANCER; GENE EXPRESSION; TRANSCRIPTION FACTOR;

AMINO ACID MOTIFS; ANIMALS; BASE SEQUENCE; CARCINOMA; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC;

EID: 84910010333     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.07.049     Document Type: Article

References (28)

1. Chung J., Noh H., Park K.H., Choi E., Han A. Longer survival in patients with breast cancer with cyclin d1 over-expression after tumor recurrence: longer, but occupied with disease. J. Breast Cancer 2014, 17:47-53.
2. Pestell R.G. New roles of cyclin D1. Am. J. Pathol 2013, 183:3-9.
3. Ye S., Lee K.B., Park M.H., Lee J.S., Kim S.M. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway. Int. J. Oncol 2014, 44:2153-2159.
4. Rivadeneira D.B., Mayhew C.N., Thangavel C., Sotillo E., Reed C.A., Graña X., et al. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology 2010, 138:1920-1930.
5. Srivastava V., Patel B., Kumar M., Shukla M., Pandey M. Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac. J. Cancer Prev 2013, 14:2711-2715.
6. Hu H., Li Z., Chen J., Wang D., Ma J., Wang W., et al. P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells. Gut 2011, 60:710-721.
7. Zhou W., Ye X.L., Sun Z.J., Ji X.D., Chen H.X., Xie D. Overexpression of degenerative spermatocyte homolog 1 up-regulates the expression of cyclin D1 and enhances metastatic efficiency in esophageal carcinoma Eca109 cells. Mol. Carcinog 2009, 48:886-894.
8. Yao F., Zhao T., Zhong C., Zhu J., Zhao H. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma. Tumour Biol 2013, 34:25-31.
9. Wang W., Xue L., Wang P. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med. Oncol 2011, 28:163-169.
10. Naganuma S., Whelan K.A., Natsuizaka M., Kagawa S., Kinugasa H., Chang S., et al. Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. Am. J. Cancer Res 2012, 2:459-475.
11. Emhemmed F., Ali Azouaou S., Thuaud F., Schini-Kerth V., Désaubry L., Muller C.D., et al. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway. Biochem. Pharmacol 2014, 89:185-196.
12. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
13. Looijenga L.H., Stoop H., De Leeuw H.P., De Gouveia Brazao C.A., Gillis A.J., van Roozendaal K.E., et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003, 63:2244-2250.
14. Amini S., Fathi F., Mobalegi J., Sofimajidpour H., Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat. Cell. Biol 2014, 47:1-11.
15. Cao L., Li C., Shen S., Yan Y., Ji W., Wang J., et al. OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer 2013, 13:82.
16. Bretones G., Delgado M.D., León J. Myc and cell cycle control. Biochim. Biophys. Acta 2014, 10.1016/j.bbagrm.2014.03.013.
17. Duronio R.J., Xiong Y. Signaling pathways that control cell proliferation. Cold Spring Harb. Perspect. Biol 2013, 5:a008904.
18. Lim S., Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 2013, 140:3079-3093.
19. Tane S., Ikenishi A., Okayama H., Iwamoto N., Nakayama K.I., Takeuchi T. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes. Biochem. Biophys. Res. Commun 2014, 443:1105-1109.
20. Zhang C.Y., Bao W., Wang L.H. Downregulation of p16ink4a inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells. Int. J. Mol. Med 2014, 33:1577-1585.
21. Benzeno S., Lu F., Guo M., Barbash O., Zhang F., Herman J.G., et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006, 25:6291-6303.
22. Kim S.H., Chau G.C., Jang Y.H., Lee S.I., Pyo S., Um S.H. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma. Hum. Pathol 2013, 44:226-236.
23. Shiozaki H., Doki Y., Yamana H., Isono K. A multi-institutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadherin in superficial squamous cell carcinoma of the esophagus. J. Surg. Oncol 2002, 79:166-173.
24. Mathew R., Arora S., Khanna R., Mathur M., Shukla N.K., Ralhan R. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Eur. J. Cancer 2002, 38:832-841.
25. Casimiro M.C., Velasco-Velázquez M., Aguirre-Alvarado C., Pestell R.G. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present. Expert Opin. Investig. Drugs 2014, 23:295-304.
26. Gu Y., Zhang S., Wu Q., Xu S., Cui Y., Yang Z., et al. Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer. J. Exp. Clin. Cancer Res 2010, 29:6.
27. Tsai L.L., Hu F.W., Lee S., Yu C.H., Yu C.C., Chang Y.C. Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PLoS ONE 2014, 9:e87207.
28. Li C., Yan Y., Ji W., Bao L., Qian H., Chen L., et al. OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS ONE 2012, 7:e49693.